TY - JOUR
T1 - Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease
T2 - Improving Global Outcomes (KDIGO) Controversies Conference
AU - Conference Participants
AU - Eckardt, Kai Uwe
AU - Delgado, Cynthia
AU - Heerspink, Hiddo J.L.
AU - Pecoits-Filho, Roberto
AU - Ricardo, Ana C.
AU - Stengel, Bénédicte
AU - Tonelli, Marcello
AU - Cheung, Michael
AU - Jadoul, Michel
AU - Winkelmayer, Wolfgang C.
AU - Kramer, Holly
AU - Al-Aly, Ziyad
AU - Ashuntantang, Gloria E.
AU - Boor, Peter
AU - Calice da Silva, Viviane
AU - Coleman, Jill
AU - Coresh, Josef
AU - Delanaye, Pierre
AU - Ebert, Natalie
AU - Enghard, Philipp
AU - Feldman, Harold I.
AU - Fisher, Lori
AU - Flythe, Jennifer E.
AU - Fukui, Akira
AU - Grams, Morgan E.
AU - Ix, Joseph H.
AU - Jardine, Meg J.
AU - Jha, Vivek
AU - Ju, Wenjun
AU - Jurish, Robert
AU - Kalyesubula, Robert
AU - Kashihara, Naoki
AU - Levey, Andrew S.
AU - Levin, Adeera
AU - Luyckx, Valerie
AU - Małyszko, Jolanta
AU - Manski-Nankervis, Jo Anne
AU - Navaneethan, Sankar D.
AU - Obrador, Greg
AU - Ortiz, Alberto
AU - Ortiz, John
AU - Cardoso Dos Santos, Bento Fortunato
AU - Sarnak, Mark J.
AU - Schaeffner, Elke
AU - Selby, Nick M.
AU - Simpson, David M.
AU - Solá, Laura
AU - St. Peter, Wendy L.
AU - Stevens, Paul E.
AU - Tangri, Navdeep
N1 - Publisher Copyright:
© 2023 KDIGO: Kidney Disease Improving Global Outcomes
PY - 2023/11
Y1 - 2023/11
N2 - Chronic kidney disease (CKD) affects over 850 million people globally, and the need to prevent its development and progression is urgent. During the past decade, new perspectives have arisen related to the quality and precision of care for CKD, owing to the development of new tools and interventions for CKD diagnosis and management. New biomarkers, imaging methods, artificial intelligence techniques, and approaches to organizing and delivering healthcare may help clinicians recognize CKD, determine its etiology, assess the dominant mechanisms at given time points, and identify patients at high risk for progression or related events. As opportunities to apply the concepts of precision medicine for CKD identification and management continue to be developed, an ongoing discussion of the potential implications for care delivery is required. The 2022 KDIGO Controversies Conference on Improving CKD Quality of Care: Trends and Perspectives examined and discussed best practices for improving the precision of CKD diagnosis and prognosis, managing the complications of CKD, enhancing the safety of care, and maximizing patient quality of life. Existing tools and interventions currently available for the diagnosis and treatment of CKD were identified, with discussion of current barriers to their implementation and strategies for improving the quality of care delivered for CKD. Key knowledge gaps and areas for research were also identified.
AB - Chronic kidney disease (CKD) affects over 850 million people globally, and the need to prevent its development and progression is urgent. During the past decade, new perspectives have arisen related to the quality and precision of care for CKD, owing to the development of new tools and interventions for CKD diagnosis and management. New biomarkers, imaging methods, artificial intelligence techniques, and approaches to organizing and delivering healthcare may help clinicians recognize CKD, determine its etiology, assess the dominant mechanisms at given time points, and identify patients at high risk for progression or related events. As opportunities to apply the concepts of precision medicine for CKD identification and management continue to be developed, an ongoing discussion of the potential implications for care delivery is required. The 2022 KDIGO Controversies Conference on Improving CKD Quality of Care: Trends and Perspectives examined and discussed best practices for improving the precision of CKD diagnosis and prognosis, managing the complications of CKD, enhancing the safety of care, and maximizing patient quality of life. Existing tools and interventions currently available for the diagnosis and treatment of CKD were identified, with discussion of current barriers to their implementation and strategies for improving the quality of care delivered for CKD. Key knowledge gaps and areas for research were also identified.
KW - chronic kidney disease
KW - models of care
KW - patient-reported outcome measures
KW - precision medicine
UR - http://www.scopus.com/inward/record.url?scp=85169818182&partnerID=8YFLogxK
U2 - 10.1016/j.kint.2023.05.013
DO - 10.1016/j.kint.2023.05.013
M3 - Article
C2 - 37245565
AN - SCOPUS:85169818182
SN - 0085-2538
VL - 104
SP - 888
EP - 903
JO - Kidney International
JF - Kidney International
IS - 5
ER -